Industries > Pharma > Orphan Drugs Market Report 2018-2028

Orphan Drugs Market Report 2018-2028

Forecasts and Analysis by Therapeutic Class (Oncology, Alimentary Tract & Metabolism, Hormonal Disorders & Haematology, Neuroscience, Respiratory, Cardiovascular, Nephrology and Ophthalmology), Drug Class (Biologic, Small Molecule) & by Region Plus Analysis of Leading Companies

PUBLISHED: 30 January 2018
PAGES: 173
PRODUCT CODE: PHA0280
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0280 Categories: , Tag:

• Do you need definitive Orphan Drugs market data?
• Succinct Orphan Drugs market analysis?
• Technological insight?
• Actionable business recommendations?

Read on to discover how this definitive report can transform your own research and save you time.

The Global Orphan Drugs market shows immense potential to grow in the future, growing in line with some emerging trends. One such trend is the increasing strategic partnerships in a move to introduce or diversify product portfolios pertaining to drugs. Another trend is advances in biomedical sciences and introduction of nanotechnologies in the global pharmaceutical market, which are revolutionising the development of medicines.

Lastly, the study of the pathogenesis of disease at genetic and molecular level studies have led to the discovery of new targets for therapy and producing disease modifying drugs.

Orphan Drugs Market Report 2018-2028

Report highlights

• 149 quantitative tables, charts, and graphs across 173 pages

• Global Orphan Drugs market outlook and analysis from 2018-2028

• Global Orphan Drugs submarket forecasts and analysis from 2018-2028
• Oncology
• Alimentary Tract & Metabolism
• Hormonal Disorders & Haematology
• Neuroscience
• Respiratory
• Cardiovascular
• Nephrology

• Key National Orphan Drugs market forecasts 2018-2028
• US forecast 2018-2028
• Germany forecast 2018-2028
• UK forecast 2018-2028
• France forecast 2018-2028
• Italy forecast 2018-2028
• Spain forecast 2018-2028
• Japan forecast 2018-2028
• Singapore forecast 2018-2028
• South Korea forecast 2018-2028
• Brazil forecast 2018-2028
• Russia forecast 2018-2028
• China forecast 2018-2028
• Brazil forecast 2018-2028

Key questions answered
• What does the future hold for the Pharmaceutical industry with regards to Orphan Drugs
• Where should you target your business strategy?
• Which applications should you focus upon?
• Which disruptive technologies should you invest in?
• Which companies should you form strategic alliances with?
• Which company is likely to success and why?
• What business models should you adopt?
• What industry trends should you be aware of?

Target audience
• Leading Pharmaceutical companies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO’s
• CIO’s
• COO’s
• Business development managers
• Investors
• Governments
• Agencies
• Banks

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Orphan Drugs Market Report 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Orphan Drugs Market Report 2018-2028


Latest Pharma news

Visiongain Publishes CRO Regulatory Services for Generics and Biosimilars Drugs Market Report 2020-2030

Growing demand for contract manufacturing services; concentrating on core competencies of pharmaceutical and biopharmaceutical companies; and increasing demand for biosimilars and generics are key factors driving the global CRO regulatory services for the generic and biosimilar drug market.

12 August 2020

READ

Vsiongain Publishes Asthma & COPD Therapies Market Report 2020-2030

Increasing pollution in emerging economies has resulted in degradation of air quality which is one of the major reasons for increasing COPD and asthma prevalence amongst children and teenagers.

11 August 2020

READ

Visiongain Publishes Pharma Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

10 August 2020

READ

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Categories

Category